CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,598 enrolled
Drug / intervention
Audit-Feedbackbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01052545
NCT01052545N/ACompleted
CompareCT.gov

Guideline Implementation to Decrease Inappropriate Bacteriuria Treatment

VA Office of Research and Development·interventional·Posted Jan 20, 2010·Updated Feb 25, 2019

In Brief

A clinical study evaluating Audit-Feedback for Infection Due to Indwelling Urinary Catheter and Asymptomatic Bacteriuria. Completed, enrolled 1,598 participants across 1 site.

Detailed Summary

Overtreatment of asymptomatic bacteriuria (ABU) is a quality, safety, and cost issue, particularly as unnecessary antibiotics lead to emergence of resistant pathogens. The investigators' proposal to bring clinical practice in line with published guidelines has significant potential to reduce unnecessary antibiotic use for ABU in the VA healthcare system, thus improving the quality and safety of veterans' healthcare. The investigators' study will also provide important insights about how to implement and sustain evidence-based clinical practice within VA hospitals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection Due to Indwelling Urinary Catheter, Asymptomatic Bacteriuria
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 20, 2010
Enrollment StartJul 1, 2011
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 16.4 years ago

Interventions

Audit-Feedbackbehavioral

Applied as a post-prescription antimicrobial review based on established guidelines.